Corrigendum to “Post Hoc Analysis of a Phase 2 Randomized Trial of Pemafibrate in Metabolic Dysfunction–associated Steatotic Liver Disease: Associations With Platelet Count, Liver Stiffness, and Spleen Volume” [J Clin Exp Hepatol 16 (4) (2026) 103525]

Journal of Clinical and Experimental Hepatology · Elsevier

Аннотация

Publication date: Available online 20 October 2026 Source: Journal of Clinical and Experimental Hepatology Author(s): Ryohei Tanigawa, Rohit Loomba, Yuichiro Eguchi, Hirokazu Takahashi, Hideki Suganami, Masaya Tanahashi, Andrey Belous, Atsushi Nakajima

Читать у издателя →

Похожие статьи